HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-52 Cr | ₹-26 Cr | ₹42 Cr | ₹112 Cr | ₹-18 Cr |
What is the latest Cash Flow from Financing Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹112 Cr |
| Mar2021 | ₹-18 Cr |
How is Cash Flow from Financing Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹42 Cr | -62.56 | |
| Mar2022 | ₹112 Cr | Positive | |
| Mar2021 | ₹-18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,340.2 Cr | -1.3% | -4.4% | -34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -1.3% |
-4.4% |
-34.1% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses